The increasing impact of precision research models on drug discovery and development

Drug Discovery World features Taconic Biosciences outlining the advancements made of genetically engineered models:

The increasing impact of precision research models on drug discovery and development"In a Challenges and Opportunities report issued by the US Food and Drug Administration (FDA), it was noted that the inability to predict lack of effectiveness and safety problems before human testing or early in clinical trials dramatically escalates costs of drug development.

According to the FDA, drug developers could save $100 million in development costs per drug with a 10% improvement in predicting failures before clinical trials."

Read the complete article at: DDW-Online.com